urethane has been researched along with HIV Coinfection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takamatsu, Y | 1 |
| Aoki, M | 1 |
| Bulut, H | 1 |
| Das, D | 2 |
| Amano, M | 2 |
| Sheri, VR | 1 |
| Kovari, LC | 1 |
| Hayashi, H | 1 |
| Delino, NS | 1 |
| Ghosh, AK | 2 |
| Mitsuya, H | 2 |
| Altavilla, G | 1 |
| Caputo, A | 1 |
| Trabanelli, C | 1 |
| Brocca Cofano, E | 1 |
| Sabbioni, S | 1 |
| Menegatti, MA | 1 |
| Barbanti-Brodano, G | 1 |
| Corallini, A | 1 |
| Randolph, JT | 1 |
| DeGoey, DA | 1 |
| Koh, Y | 1 |
| Li, J | 1 |
| Leschenko, S | 1 |
| Wang, YF | 1 |
| Boross, PI | 1 |
| Weber, IT | 1 |
1 review available for urethane and HIV Coinfection
| Article | Year |
|---|---|
Peptidomimetic inhibitors of HIV protease.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; Dipeptides; Furans; HIV; | 2004 |
3 other studies available for urethane and HIV Coinfection
| Article | Year |
|---|---|
Novel Protease Inhibitors Containing C-5-Modified
Topics: Benzimidazoles; Cell Line; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Viral; Enzyme St | 2019 |
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane.
Topics: Animals; Carcinogens; Cell Division; DNA, Complementary; Female; Gene Products, tat; HIV Infections; | 2004 |
A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro.
Topics: Amino Acid Sequence; Drug Design; Drug Resistance, Multiple, Viral; Furans; HIV Infections; HIV Prot | 2007 |